Small-Animal Imager to Enable Advanced Disease Research
 |
Analogic affords its customers capabilities in developing and manufacturing solutions for molecular imaging. We have developed and manufacture a full system for small-animal imaging based on molecular marker technology called fluorescent molecular tomography (FMT). VisEn Medical of Bedford, Massachusetts, came to Analogic looking for an engineering and manufacturing partner to help produce an in-vivo small-animal imager based on its proprietary fluorescence imaging agents. Shortly after reaching an agreement with VisEn, Analogic shipped the first workable prototype of this self-contained imaging system, complete with laser, camera, and controls. | This first-of-its-kind system uses a near-infrared laser to cause tumorous cells to fluoresce, producing a true 3-D image of the affected tissue. A number of pharmaceutical companies and academic centers are currently using this technology to investigate the efficacy of various drug therapies. A second-generation system, the FMT 2500, was introduced in 2007. As a technology enabler, Analogic provides the engineering and manufacturing resources to small start-up companies, like VisEn, allowing them to bring their revolutionary products to market in a timely and cost-effective way. For more information on how we can help you in molecular imaging, contact medicalsales@analogic.com.
 |
Testimonial“As we were exploring how best to manufacture our Fluorescence Molecular Tomography FMT-1 and FMT2500 product lines, VisEn felt that Analogic would be an ideal partner manufacturer due to their deep experience as a leading OEM provider of clinical-quality medical imaging subsystems. We are very pleased with how strong a partner Analogic has been with our systems engineering team through the production and commercial phases. Our product and our customers have certainly benefited from Analogic’s industry-leading quality and product development tollgate processes, and we look forward to continued growth with Analogic into the future.” Dr. W. Yared, Chief Technology Officer, VisEn Medical |
|